Clinical Trial Detail

NCT ID NCT01814501
Title Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors Christina Wu
Indications

colon adenocarcinoma

rectum adenocarcinoma

colorectal adenocarcinoma

Therapies

Fluorouracil + Irinotecan + Leucovorin

Panitumumab

Age Groups: adult

Additional content available in CKB BOOST